Speciality European Pharma
Latest round
- Series B
Last raised
- Aug 2008
Total raised
- $43M
Investors
- 3
About Speciality European Pharma
Speciality European Pharma Limited operates in the pharmaceutical sector, concentrating on specialty medications.75 mn from Beringea Private Equity on January 14, 2015. The company has been strategically positioned without any referenced changes in business operations or ownership structure.Speciality European Pharma focuses on providing a range of pharmaceutical products dedicated to addressing specific medical needs within various therapeutic areas. The company's core offerings include specialty medicines designed for conditions requiring targeted medical interventions, such as rare diseases and complex health concerns. These products enhance patient outcomes by offering innovative treatment options that are not widely available in conventional healthcare settings.80. The company primarily generates revenue through direct sales to healthcare institutions and specialty pharmacies, operating within a B2B model. Transactions typically involve the procurement of specialty pharmaceuticals under negotiated contracts, which may include volume-based pricing agreements.Speciality European Pharma aims to expand its product offerings by developing new specialty medicines tailored to market needs, with anticipated launches in the coming years. The company is also focusing on expanding into new geographic regions, specifically targeting markets in Eastern Europe by 2024.75 mn will be utilized to support these initiatives, including product development and market entry strategies, enhancing the company’s capacity to meet emerging healthcare demands.
Who invested in Speciality European Pharma
3 investors across 3 rounds
See all investors in Speciality European Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Speciality European Pharma
Who invested in Speciality European Pharma?
Speciality European Pharma has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Speciality European Pharma raised?
Speciality European Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Speciality European Pharma last raise money?
Speciality European Pharma's most recent round on record is a Series B, in Aug 2008.
What does Speciality European Pharma do?
Speciality European Pharma Limited operates in the pharmaceutical sector, concentrating on specialty medications.
Where is Speciality European Pharma headquartered?
Speciality European Pharma is headquartered in London, UK.
Which VCs invest in companies like Speciality European Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Speciality European Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Speciality European Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.